Drug Pricing Shake Up Likely In Germany
Top Pricing And Reimbursement Authority Wants To Slash Free Pricing Period
Executive Summary
The umbrella organization for public insurers is also expected to publish its own suggestions on how to cut spending on pharmaceuticals, including interim prices for conditionally approved drugs.